跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 86 条关于
“DESMODA”
全部
86
临床试验
74
药物
1
机构
0
资讯
11
6个月前
FDA Approves First Oral Liquid Desmopressin Solution for Central Diabetes Insipidus
去年
Nirogacestat Shows Deepening Long-Term Responses in Desmoid Tumor Patients
8个月前
Merck's Ogsiveo Becomes First Approved Desmoid Tumor Treatment in Europe
去年
Ipilimumab and Nivolumab Show Promise in Treating Rare Desmoid Tumors
去年
OGSIVEO Shows Long-Term Efficacy and Safety in Desmoid Tumors
去年
SpringWorks Anticipates CHMP Opinion on Nirogacestat for Desmoid Tumors in Q2 2025
9个月前
Immunome Prepares to Release Phase 3 RINGSIDE Trial Results for Varegacestat in Desmoid Tumors
去年
Ogsiveo (Nirogacestat) Shows Sustained Efficacy in Desmoid Tumors: Long-Term Phase 3 Data
10个月前
FDA Grants Fast Track Designation to FOG-001, First-in-Class β-Catenin Inhibitor for Desmoid Tumors
9天前
Parabolus Medicines' zolocatetide posts 74% response rate in desmoid tumors, targeting the undruggable beta-catenin/TCF complex
第 1 页,共 2 页
上一页
下一页